Moreover, high levels of anti-WT1 antibody (Ab) in serum were found to be a prognostic factor of longer survival in patients with MDS and in patients with non-small cell lung cancer (NSCLC) 37,38. This evidence concerns the gene WT1 and myelodysplastic syndrome.